GGrantIndex
Sort

326,823 grants matching clinical trial

Childhood Cancer Survivor Study

$4,218,764
Gregory Armstrong · St. Jude Children'S Research Hospital · U24 · FY2018 · CA

WASHINGTON UNIVERSITY INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCES

$4,218,331
Kenneth S Polonsky · Washington University · UL1 · FY2010 · RR

Methocinnamox (MCAM): A novel µ-opioid receptor antagonist for opioid use disorders

$4,218,078
Charles P France · University Of Texas Hlth Science Center · UH3 · FY2023 · DA

Project 2: PanbetaCoV protein vaccine design

$4,217,384
Kevin Wiehe · Duke University · P01 · FY2021 · AI

UCLA AIDS Prevention and Treatment Clinical Trials Unit

$4,216,430
Judith S. Currier · University Of California Los Angeles · UM1 · FY2012 · AI

Neuroblastoma Tumor Microenvironment: tumor growth and immune regulation

$4,216,302
Carol Thiele-Galetto · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

MSC Therapy & Immune Response in Children with Osteogenesis Imperfecta

$4,215,211
Edwin M Horwitz · Children'S Hosp Of Philadelphia · RC4 · FY2010 · AR

UAB-ZAMBIA-HAITI HIV PREVENTION TRIALS UNIT

$4,214,816
University Of Alabama At Birmingham · U01 · FY2002 · AI

Statistics Core

$4,214,671
Greg Yothers · University Of Chicago · U10 · FY2024 · CA

LOW FAT DIET AND BREAST CANCER RECURRENCE--OUTCOME TRIAL

$4,213,792
Institute For Cancer Prevention · R01 · FY2000 · CA

Development Of A Multicomponent HIV-1 Recombinant Adenoviral Vector Vaccine

$4,212,877
Richard Schwartz · National Institute Of Allergy And Infectious Diseases · ZIB · FY2009 · AI

Development And Production Of A Multiclade HIV-1 DNA Plasmid Vaccine

$4,212,877
Richard Schwartz · National Institute Of Allergy And Infectious Diseases · ZIB · FY2009 · AI

CTSA INFRASTRUCTURE FOR CLINICAL TRIALS

$4,212,644
Daniel Ernest Ford · Johns Hopkins University · UL1 · FY2011 · RR

Rationally designed targeted immunogens to elicit HIV Envelope V2-apex broadly neutralizing antibodies

$4,211,839
Raiees Ahmad Andrabi · University Of Pennsylvania · U19 · FY2025 · AI

Clinical Trials of Biodefense Vaccines (Dengue)

$4,211,550
Kanta Subbarao · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI

PREVENTION OF ALZHEIMER DEMENTIA &COGNITIVE DECLINE

$4,211,104
University Of Washington · U01 · FY2004 · AG

Kaiser Permanente NCI National Community Oncology Research Program, NCORP

$4,211,097
Jennifer Marie Suga · Kaiser Foundation Research Institute · UG1 · FY2019 · CA

The Epilepsy Bioinformatics Study for Antiepileptogenic Therapy (EpiBioS4Rx)

$4,209,866
Arthur W Toga · University Of Southern California · U54 · FY2019 · NS

Community-Based HIV VCT: South Africa

$4,209,595
Thomas J. Coates · University Of California Los Angeles · U01 · FY2009 · MH

Assessment of Biomarker Guided CNI Substitution in Kidney Transplantation

$4,209,374
Peter Scott Heeger · Cedars-Sinai Medical Center · U01 · FY2023 · AI

The University of North Carolina Center for AIDS Research

$4,209,183
Ronald I Swanstrom · Univ Of North Carolina Chapel Hill · P30 · FY2021 · AI

Allogeneic and Autologous Immunotherapy for cancer and nonmalignant hematological disorders

$4,208,801
Richard Childs · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL

Cancer Center Support Grant

$4,207,812
Timothy J Eberlein · Washington University · P30 · FY2018 · CA

CLINICAL TRIALS AND INFORMATION MANAGEMENT SUPPORT

$4,207,634
Claudia Valmonte · The Emmes Company, Llc · N01 · FY2021 · CA

Idaho INBRE Program

$4,206,381
Carolyn Hovde Bohach · University Of Idaho · P20 · FY2024 · GM